Univ. Prof. Dr. Heinz Redl
From 1998 to 2019, Prof. Heinz Redl was head of the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology (LBI Trauma) within the main trauma research center of the AUVA, representing seven trauma centers and four rehabilitation centers.
The scientist is the founder of Trauma Care Consult, where he also acts as CEO and a co-founder of the two companies Liporegena and MorphoMed. His goals are to improve the diagnostic and therapeutic possibilities for accident patients and to create new national and international networks. In 2006, the Austrian tissue regeneration cluster was launched, for which he still works as a coordinator. Subsequently, he was also involved in the foundation of the European Institute of Excellence for Tissue Engineering and Regenerative Medicine (Expertissue). He also has a consulting role with multiple companies covering product registration at FDA and EMA.
Prof. Redl was and is a member of numerous societies, as well as a board member of TERMIS (Tissue Engineering and Regenerative Medicine International Society). He was President of the European Shock Society and the TERMIS-EU chapter. Moreover, he was a member of several editorial boards of numerous scientific journals. These include the Journal of Tissue Engineering and Regenerative Medicine, the European Journal for Trauma and Emergency Surgery, Frontiers in Tissue Engineering and Regenerative Medicine and many more. The researcher has published more than 550 PubMed cited articles and holds more than 10 patents. He organized numerous conferences, including the World Congress for Tissue Engineering TERMIS 2012. He participated in multiple EC-Projects (European Commission), including Expertissues, Angioscaff, Biodesign, IMCOSS, UGEN, etc. One of his most treasured projects is the publication of the Springer book series "Biomedical Engineering - Tissue Engineering and Regeneration" which is regularly updated by leading scientists and can be printed on demand.
His expertise includes: Experience in different fields of tissue regeneration, co-developer of the fibrin sealant system (>30 years), developer of surgical devices in current clinical use and many collaboration projects with major industry partners.
In the course of his career, the scientist received numerous awards, including the research award from the Austrian Society for Clinical Chemistry, the Lorenz-Böhler Medal and the Wilhelm Exner Medal.